| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/04/1996 | WO1996020216A1 Fibronectin adhesion inhibitors |
| 07/04/1996 | WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | WO1996020214A1 Tcf mutant |
| 07/04/1996 | WO1996020213A1 Recombinant antigen for diagnosing rheumatoid arthritis |
| 07/04/1996 | WO1996020207A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
| 07/04/1996 | WO1996020206A1 Secreted human fas antigen |
| 07/04/1996 | WO1996020013A1 Improvements in or relating to endometrial function |
| 07/04/1996 | WO1996020005A1 Protracted glp-1 compositions |
| 07/04/1996 | WO1996020004A1 Therapeutic agent for disorder of lipid metabolism |
| 07/04/1996 | WO1996020003A1 Methods for treatment or diagnosis of diseases or disorders associated with an apb domain |
| 07/04/1996 | WO1996020002A1 Immobilization of peptides to hyaluronate |
| 07/04/1996 | WO1996020001A1 Transmucosal preparation |
| 07/04/1996 | WO1996019999A1 Thrombolytic enzyme and method of obtaining same |
| 07/04/1996 | WO1996019918A1 Plasma expanders and blood substitutes |
| 07/04/1996 | WO1996011664A3 NSK2 a muscle receptor tyrosine kinase |
| 07/04/1996 | CA2211038A1 Secreted human fas antigen |
| 07/04/1996 | CA2209016A1 Pharmaceutics for mucosal administration |
| 07/04/1996 | CA2208706A1 Mutants of the rb and p53 genes and uses thereof |
| 07/04/1996 | CA2208502A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | CA2208446A1 Improvements in or relating to endometrial function |
| 07/04/1996 | CA2208319A1 Assay, receptor proteins and ligands |
| 07/04/1996 | CA2208291A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use |
| 07/04/1996 | CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | CA2208072A1 Recombinant antigen for diagnosing rheumatoid arthritis |
| 07/04/1996 | CA2207820A1 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| 07/04/1996 | CA2204793A1 Fibronectin adhesion inhibitors |
| 07/04/1996 | CA2184248A1 Therapeutic agent for disorder of lipid metabolism |
| 07/04/1996 | CA2182946A1 Human phosphodiesterase type ivc, and its production and use |
| 07/03/1996 | EP0719864A2 Recombinant live avian vaccin, using an avian herpes virus as vector |
| 07/03/1996 | EP0719860A1 Compositions and method for treating or preventing infections in animals |
| 07/03/1996 | EP0719859A1 Anti-alpha V-integrin monoclonal antibody |
| 07/03/1996 | EP0719792A2 Somatotropin variants |
| 07/03/1996 | EP0719791A2 Medicaments for the treatment of restenosis and arterial sclerosis |
| 07/03/1996 | EP0719779A1 Substituted thiazolo [3,2-alpha]azepine derivative |
| 07/03/1996 | EP0719561A1 Percutaneously absorbable preparation |
| 07/03/1996 | EP0719560A1 Antibordetella acellular vaccine |
| 07/03/1996 | EP0719558A1 Ranolazine and related piperazines for use in the treatment of shock conditions |
| 07/03/1996 | EP0719343A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/03/1996 | EP0719340A1 Cloned glutamic acid decarboxylase |
| 07/03/1996 | EP0719336A1 Modified plant viruses as vectors of heterologous peptides |
| 07/03/1996 | EP0719334A1 Pharmaceutical compositions containing ecotin and homologs thereof |
| 07/03/1996 | EP0719332A1 Monocyte macrophage line recombinant cells for gene therapy |
| 07/03/1996 | EP0719331A1 Eotaxin = eosinophil chemotactic cytokine |
| 07/03/1996 | EP0719330A1 Protocadherin proteins and their uses |
| 07/03/1996 | EP0719329A1 Human receptor h4-1bb |
| 07/03/1996 | EP0719328A1 Grb3-3 gene, variants and uses thereof |
| 07/03/1996 | EP0719295A1 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/03/1996 | EP0719286A1 Dextran esters, process for producing them and their use for encasing and encapsulating medicaments |
| 07/03/1996 | EP0719285A1 Il8 inhibitors |
| 07/03/1996 | EP0719284A1 Improvements in or relating to haemoglobin |
| 07/03/1996 | EP0719283A1 Factor for fibroblast colony forming unit |
| 07/03/1996 | EP0719282A1 Aids prophylactics |
| 07/03/1996 | EP0719281A1 Multiple branch peptide constructions for use against hiv |
| 07/03/1996 | EP0719279A1 Process for purifying 1- n(2 -((s)-ethoxycarbonyl)-3-phenylpropyl)-n6 -trifluoroacetyl]-l-lysyl-l-prolin (lisinopril(tfa)ethylester) |
| 07/03/1996 | EP0719274A1 Method for dosing therapeutic compounds |
| 07/03/1996 | EP0719273A1 Nucleotide analogs |
| 07/03/1996 | EP0719155A1 $i(CAMPYLOBACTER JEJUNI) ANTIGENS, AND METHODS FOR THEIR PRODUCTION AND USE |
| 07/03/1996 | EP0719154A1 Activated factor viii as a therapeutic agent and method of treating factor viii deficiency |
| 07/03/1996 | EP0719153A1 Inhibition of heparin-binding |
| 07/03/1996 | EP0719150A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
| 07/03/1996 | EP0719147A1 Gene therapy for solid tumors, papillomas and warts |
| 07/03/1996 | EP0719134A1 Skin care composition comprising thiol proteases from the stratum corneum |
| 07/03/1996 | EP0719133A1 Skin care method and composition |
| 07/03/1996 | EP0719132A1 Skin care method and composition |
| 07/03/1996 | EP0673653A4 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it. |
| 07/03/1996 | EP0673652A4 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it. |
| 07/03/1996 | EP0669836B1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/03/1996 | EP0441955B1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
| 07/03/1996 | EP0249613B1 Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4) |
| 07/03/1996 | CN1125952A Process for manufacture of 1-deamino-8-D-arginine vasopressin |
| 07/03/1996 | CN1032190C Method for reducing side effects of drug |
| 07/02/1996 | US5532366 Enzyme inhibitors |
| 07/02/1996 | US5532359 Fungicides |
| 07/02/1996 | US5532352 Chemically modifying hemoglobin for use in a blood substitute |
| 07/02/1996 | US5532343 Purification and characterization of a glioma-derived growth factor having vascular endothelial cell growth promoting activity |
| 07/02/1996 | US5532341 Polypeptides for stimulating growth of bone marrow cells |
| 07/02/1996 | US5532340 Tumor suppressor protein PRB2, related gene products, and DNA encoding therefor |
| 07/02/1996 | US5532339 Fusion protein between human macif and a heterologous pi anchor domain |
| 07/02/1996 | US5532337 Proteins comprising calmodulin- and actin-binding human caldesmon polypeptide fragments |
| 07/02/1996 | US5532336 Anti-obesity proteins |
| 07/02/1996 | US5532265 Administering n-(2r-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl-l-trypt ophan methylamine to a mammal |
| 07/02/1996 | US5532220 Of mammarian cancer cells lacking endogeneous protein; introducing suppressor gene encoding protein into cells |
| 07/02/1996 | US5532217 Process for the mineralization of collagen fibers, product produced thereby and use thereof to repair bone |
| 07/02/1996 | US5532216 Neutralization of non-lipopolysaccharide compounds by bactericidal/permeability-increasing protein |
| 07/02/1996 | US5532215 Antiviral compositions and method of use |
| 07/02/1996 | US5532214 Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and therapeutic uses thereof |
| 07/02/1996 | US5532169 Quantitating concentration of peptides in body fluids and collagen telopeptides with hydroxylysyl pyridoline crosslinking |
| 07/02/1996 | US5532159 Antitumor agents; hybridomas |
| 07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
| 07/02/1996 | US5532150 Immobilized superoxide dismutase |
| 07/02/1996 | US5532144 Process for preparing human derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human body |
| 07/02/1996 | US5532127 Assay for 1-CAM related protein expression |
| 07/02/1996 | US5532123 Receptor-type phosphotyrosine phosphatase-γ |
| 07/02/1996 | US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates |
| 07/02/1996 | CA2078347C Use of copper(ii) containing compounds to accelerate wound healing |
| 06/28/1996 | CA2153129A1 Method of treating birds |
| 06/27/1996 | WO1996019584A1 Chimeric antibodies comprising antigen binding sites and b and t cell epitopes |
| 06/27/1996 | WO1996019580A2 Telomerase protein component |
| 06/27/1996 | WO1996019579A1 Nuclear protein serine/threonine kinases |
| 06/27/1996 | WO1996019578A2 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN ahpCF OPERON |